TMU
Owner
Tarbiat Modares University (TMU) is the owner of HEHP.
0.8
Cite Score
Volume 10, Issue 3 (2022)
Health Educ Health Promot 2022, 10(3): 477-481 |
Back to browse issues page
History
Received: 2022/03/4 | Accepted: 2022/05/9 | Published: 2022/07/5
Received: 2022/03/4 | Accepted: 2022/05/9 | Published: 2022/07/5
How to cite this article
Development and Initial Validation of the Coronavirus Pandemic Anxiety Scale. Health Educ Health Promot 2022; 10 (3) :477-481
URL: http://hehp.modares.ac.ir/article-4-60007-en.html
URL: http://hehp.modares.ac.ir/article-4-60007-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
Abstract (2495 Views)
Aims: This paper aimed to report the development and validation of the Coronavirus Pandemic Anxiety Scale, for assessing COVID-19-related anxiety.
Instrument & Methods: This is a methodological and psychometric study, we developed a 7-Item Generalized anxiety disorder of COVID-19 scale to measure symptoms of anxiety related to the COVID-19 pandemic to help identify people who might need mental health services. In developing the generalized anxiety disorder of COVID-19 scale items, we considered a previous theory and research on anxiety symptoms and symptoms reported in Iran. The scale was validated in the Razavi Khorasan (N=500).
Findings: The CVR in this study for the total scale was 0.81 indicating a satisfactory result. Also, the CVI for the scale was0.78, and the scale had good content validity. Confirmatory factor analysis showed a good fit for the seven-factor model. generalized anxiety disorder of covid-19 scale showed good internal consistency.
Conclusion: The results support the viability of generalized anxiety disorder on the COVID-19 scale as a tool to identify individuals experiencing COVID-19-related anxiety.
Instrument & Methods: This is a methodological and psychometric study, we developed a 7-Item Generalized anxiety disorder of COVID-19 scale to measure symptoms of anxiety related to the COVID-19 pandemic to help identify people who might need mental health services. In developing the generalized anxiety disorder of COVID-19 scale items, we considered a previous theory and research on anxiety symptoms and symptoms reported in Iran. The scale was validated in the Razavi Khorasan (N=500).
Findings: The CVR in this study for the total scale was 0.81 indicating a satisfactory result. Also, the CVI for the scale was0.78, and the scale had good content validity. Confirmatory factor analysis showed a good fit for the seven-factor model. generalized anxiety disorder of covid-19 scale showed good internal consistency.
Conclusion: The results support the viability of generalized anxiety disorder on the COVID-19 scale as a tool to identify individuals experiencing COVID-19-related anxiety.
Keywords:
| | Full-Text (HTML) (455 Views)